- AVXL +5.12%
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript
Yahoo Finance · 3 days ago
Open | 3.8500 |
High | 4.2600 |
Low | 3.8500 |
Mkt Cap | 338.99M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.8100 |
52 Wk. Low | 3.2500 |
52 Wk. High | 10.4500 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -10.55M | - |
Diluted EPS | -0.13 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.13 | - |
Q1 2024 | -$0.11 | -$0.13 |
Q4 2023 | -$0.14 | -$0.11 |
S&P 500^GSPC | 5,222.44-0.24 (-0.00%) |
Dow 30^DJI | 39,449.26-63.58 (-0.16%) |
Nasdaq^IXIC | 16,386.93+46.06 (+0.28%) |
31.20+78.69% | |
5.55+90.89% | |
84.46+5.53% |